| Name | Title | Contact Details |
|---|---|---|
Peter Heller |
Assistant General Counsel | Profile |
Eduardo Uribe |
VP of Quality and Regulatory Compliance | Profile |
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. Our lead program, AT-1501, is a potential best-in-class humanized IgG1 anti-CD40L antibody with high affinity for CD40L, a well-validated biological target with broad therapeutic potential. The CD40/CD40L pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation.
We offer medical, dental and behavioral health care for Alameda Countys underserved Asian and Pacific Islander community.
encompass clinical research is a Spring Valley, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Hitech Air Conditioning Inc is a Santee, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.